Quantification of tumor-specific T lymphocytes with the ELISPOT assay.
about
A modified human ELISPOT assay to detect specific responses to primary tumor cell targetsT-cell clonotypes in cancerNew flow cytometric assays for monitoring cell-mediated cytotoxicityImmunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines.The ELISPOT assay: an easily transferable method for measuring cellular responses and identifying T cell epitopes.Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma.Spontaneous regression of Hodgkin's disease: two case reports and a review of the literature.Immunological monitoring of cancer vaccine therapy.Defining ELISpot cut-offs from unreplicated test and control wells.ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials.Resting of Cryopreserved PBMC Does Not Generally Benefit the Performance of Antigen-Specific T Cell ELISPOT Assays.Immunological monitoring of the tumor immunoenvironment for clinical trials.Dendritic cell-based tumor vaccinations in epithelial ovarian cancer: a systematic review.Vaccine therapies for patients with glioblastoma.Identification of a new HLA-A*0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587.A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors.
P2860
Q24800412-ACACBB74-3057-4DD3-9988-39B985140D68Q24803891-4886653F-53BE-4559-90EB-45586BBDDF92Q34027777-F4461A14-53EF-4DED-8698-5A25B5ABF8BEQ34898366-1197C88C-F880-4562-B94D-0A7B907A537DQ34999197-D9776786-A676-4AED-908E-DA34614D46F0Q35113661-B13230A8-2AE7-4094-83A9-E206668BBFDBQ35126985-B8777F43-0AF2-4BB0-9129-9506AD5E5752Q35907052-718C36F5-C0A7-41EA-A1D8-15D67477CD11Q36852775-3ED11D7B-6B04-4BD3-8265-714A14801372Q37512173-86519A97-A8CF-4A7D-9DC1-B1736781C2BEQ37512240-7D726A9B-909C-474C-9271-42DA153D423AQ37955680-0CED68F7-01F7-4B75-959B-0FEDA18620FEQ38059513-23F4A27C-A369-4BEA-AF24-83188FC20A0BQ38243975-EB33F21A-0FEE-40BD-809F-D18DBF97B3D6Q40439479-3C6BFE8A-C1ED-4979-9339-32AED404435EQ52579555-54A8887C-5AFA-487A-88B8-9EEAEDC01BE8
P2860
Quantification of tumor-specific T lymphocytes with the ELISPOT assay.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Quantification of tumor-specific T lymphocytes with the ELISPOT assay.
@ast
Quantification of tumor-specific T lymphocytes with the ELISPOT assay.
@en
type
label
Quantification of tumor-specific T lymphocytes with the ELISPOT assay.
@ast
Quantification of tumor-specific T lymphocytes with the ELISPOT assay.
@en
prefLabel
Quantification of tumor-specific T lymphocytes with the ELISPOT assay.
@ast
Quantification of tumor-specific T lymphocytes with the ELISPOT assay.
@en
P2093
P1476
Quantification of tumor-specific T lymphocytes with the ELISPOT assay.
@en
P2093
Keilholz U
Scheibenbogen C
Schmittel A
P304
P356
10.1097/00002371-200005000-00001
P577
2000-05-01T00:00:00Z